DDM-056 - Bioequivalence study of sodium valproate and valproic acid extended release tablets in healthy human volunteers
- At: Copenhagen (Denmark) (2025)
- Type: Poster
- Poster code: DDM-056
- By: SHAKYA, Rajani (Kathmandu University, Nepal)
- Co-author(s): Prof. Rajani Shakya (Kathmandu University, Dhulikhel, Kavre, Nepal)
Dr Shailendra Shakya (Kathmandu University, Dhulikhel, Kavre, Nepal)
Dr Ashwinee Kumar Shrestha (Kathmandu University, Dhulikhel, Kavre, Nepal)
Mrs Sabhiyata Khanal (Asian Pharmaceuticals Pvt. Ltd., Rupandehi, Nepal)
Dr Ram Bahadur Gurung (Dhulikhel Hospital, Dhulikhel, Nepal) - Abstract:
Introduction
Sodium valproate and valproic acid are narrow therapeutic index medications that are widely used as anticonvulsants. In the Nepalese market, various brands of these antiepileptics are available, and switching between these brands without confirming their bioequivalence can lead to loss of seizure control. This study aimed to evaluate.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 4 September 2025